Skip to content

A Study to Check the Skin Safety of ‘Moisture IQ’ Cream in Healthy Adults Using a Patch Test

Evaluation of Irritation Potential of MOISTURE IQ through Dermatological Evaluation by Single Occlusive Patch Test on Healthy Adult Human Volunteers - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096480
Enrollment
24
Registered
2025-10-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: MOISTURE IQ: Ingredients: Bees Wax, Shea Butter, Coconut oil, Magnesium Oil, Jojoba oil, Vitamin E oil. study Duration: 8 days Control Intervention1: NA: NA

Sponsors

Dermesse Raw and Naturals Private Limited., India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Healthy participants with healthy skin on the studied anatomic unit (free of eczema, wounds & any other inflammatory scar) 2.Age group of 18 to 55 years, 12 male and 12 female participants. 3.Compliance with the study procedures involved.

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women 2.Participants with any other skin disorders. 3.Use of any other topical agents for any skin related conditions (at the site of application of patch) during the past 30 days

Design outcomes

Primary

MeasureTime frame
Outcome 1. Erythema, dryness, wrinkles Oedema 2. Mean Irritation Index Scoring System (0-4): 0: No reaction 1: Very slight erythema/dryness/oedema 2: Slight erythema/dryness/oedema 3: Moderate erythema/dryness/oedema 4: Severe erythema/dryness/oedema Evaluation Process: 3. Mean scores for erythema, dryness, wrinkles, and oedema will be calculated for T1, T2, and T8 days using Microsoft Excel 2010 and GraphPad Prism software. 4. Scores will be assessed for the test sample (Vanaura Organics Products) and controls (including 1% sodium lauryl sulfate).Timepoint: T1 (0 Hours Post-Patch Removal) T2 (24 Hours Post-Patch Removal) T8 (1 Week Post-Patch Removal)

Secondary

MeasureTime frame
Adverse event monitoringTimepoint: T1 (0 Hours Post-Patch Removal) T2 (24 Hours Post-Patch Removal) T8 (1 Week Post-Patch Removal)

Countries

India

Contacts

Public ContactDr Gayathri Sivakumar

DK Elite Health Care Centre

saheerose@gmail.com09843591097

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026